# Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection

> **NCT03984747** · — · COMPLETED · sponsor: **Natera, Inc.** · enrollment: 110 (actual)

## Conditions studied

- Transplant Rejection
- Allograft Rejection
- Complications

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03984747
- **Lead sponsor:** Natera, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-14
- **Primary completion:** 2024-08-23
- **Final completion:** 2024-08-23
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03984747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03984747, "Study for the Prediction of Active Rejection in Organs Using Donor-derived Cell-free DNA Detection". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT03984747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*